Clinical Trials for Mesothelioma Patients: Valproate and Doxorubicin

Read about a current clinical trial being conducted to study Valproate and Doxorubicin in patients who have been diagnosed with mesothelioma. At this time, the study is only being conducted in Belgium and France. Please note: this information is provided by Weitz & Luxenberg for informational purposes only.

Phase II Study of Valproate and Doxorubicin in Malignant Mesothelioma
Purpose:
The purpose of this study is to determine the response rate to the combination of doxorubicin and valproate acid in patients with MM failing after at least one previous chemotherapy regimen including platinum derivatives.

Requisite Conditions:
Malignant Mesothelioma

Intervention:
Drug: Valproate plus doxorubicin

Study Phase, Type and Design
Phase II Interventional; Treatment, Non-Randomized, Open Label, Single Group Assignment, Efficacy Study

Official Title:
A Phase II Study Assessing the Activity of Valproate Acid Plus Doxorubicin in Refractory or Recurrent Malignant Mesothelioma

If you or a loved one has been doagnosed with an Asbestos illness like mesothelioma, lung cancer or asbestosis, complete the form on this page to get a FREE and prompt review of your case by a leading Asbestos attorney. Weitz & Luxenberg is a leading mesothelioma law firm with a substantial history of success in asbestos exposure cases.